Vaxxas Initiates Program With Merck to Optimize Delivery of Next Generation Vaccines Utilizing Novel Mechanism for Immune System Activation

08 October 2012

You may also like

18 June 2023

Vaxxas opens world-class manufacturing facility to produce needle-free vaccine patch

News, Announcement

06 December 2022

Needle-free vaccine innovator banks $34m

News, The Australian Financial Review

10 November 2021

Vaxxas recognised in the Top 10 healthcare startups in Australia, 2021

08 June 2021

QLD govt commits $20m to vaccine manufacturer

View All

Ventured. Gained.

Subscribe to our Newsletter.

Name
decor
decor decor decor
decor decor decor decor decor